Back to Screener

Healthcare

VistaGen Therapeutics, Inc.(VTGN)

Live Price

Offline

$0.67

-2.90% today

1Y Change

-70.41%

Window

Jun 23, 2025 โ†’ Jun 12, 2026

Market Cap
$20.00M
Revenue Growth
-54.3%
EPS Growth
-9.9%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 23, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

VistaGen Therapeutics, Inc. (VTGN) is a Healthcare stock with a market cap of $20.00M and listed on NASDAQ. The stock last traded around $0.67 and down 70.4% across the available one-year price window (Jun 23, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of -54.3%, EPS growth of -9.9%, a dividend yield of 0.0%. What stands out right now is revenue -54.3%, EPS -9.9%, free cash flow -63.4% with operating margin -8847.8% and ROIC -133.1%. Valuation already assumes a fairly strong business story at price/sales 25.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VTGN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

VTGN

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

VTGN Max Drawdown

-89.59%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for VTGN and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Next earningsJul 1, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Jul 1, 26
TBD
โ€”
Est -0.34
โ€”
โ€”
Est 401.4B
โ€”
Jul 1
โ€”
Jun 16, 26
โ€”
Est -0.34
โ€”
โ€”
Est 401.4B
โ€”
Jun 16
โ€”
Feb 12, 26
โœ“
-0.45
Est -0.51
+11.8%
303.0B
Est 364.4B
-16.9%
Feb 12
โ€”
Nov 13, 25
โœ—
-0.54
Est -0.51
-5.9%
258.0B
Est 145.8B
+77.0%
Nov 13
โ€”
Aug 7, 25
โ€”
-0.47
Est -0.47
0.0%
244.0B
Est 215.7B
+13.1%
Aug 7
โ€”
Jun 17, 25
โœ“
-0.43
Est -0.52
+17.3%
-15.0B
Est 209.3B
-107.2%
Jun 17
โ€”
Feb 13, 25
โœ“
-0.46
Est -0.48
+4.2%
234.0B
Est 182.0B
+28.6%
Feb 13
โ€”
Nov 7, 24
โœ—
-0.42
Est -0.40
-5.0%
183.0B
Est 240.0B
-23.8%
Nov 7
โ€”
Aug 13, 24
โœ“
-0.35
Est -0.41
+14.6%
84.0B
Est 300.0B
-72.0%
Aug 13
โ€”
Jun 11, 24
โœ“
-0.25
Est -0.34
+26.5%
197.3B
Est 200.0B
-1.4%
Jun 11
โ€”
Feb 13, 24
โœ“
-0.22
Est -0.31
+29.0%
411.4B
Est 200.0B
+105.7%
Feb 13
โ€”
Nov 9, 23
โœ“
-0.66
Est -0.68
+2.9%
278.0B
Est 184.6B
+50.6%
Nov 9
โ€”
Aug 10, 23
โœ—
-0.94
Est -0.86
-9.3%
177.0B
Est 180.0B
-1.7%
Aug 10
โ€”
Jun 22, 23
โœ—
-1.75
Est -1.50
-16.7%
175.6B
Est 179.6B
-2.2%
Jun 22
โ€”
Feb 7, 23
โœ“
-1.50
Est -1.80
+16.7%
179.6B
Est 90.0B
+99.6%
Feb 7
โ€”
Nov 10, 22
โ€”
-2.40
Est -2.40
0.0%
-892.5B
Est 310.1B
-387.9%
Nov 10
โ€”
Aug 11, 22
โœ—
-3.00
Est -2.70
-11.1%
310.1B
Est 238.6B
+29.9%
Aug 11
โ€”
Jun 23, 22
โœ—
-2.40
Est -1.80
-33.3%
38.9B
Est 338.6B
-88.5%
Jun 23
โ€”
Feb 10, 22
โœ“
-1.50
Est -2.40
+37.5%
357.9B
Est 338.7B
+5.7%
Feb 10
โ€”
Nov 10, 21
โœ—
-2.10
Est -1.50
-40.0%
358.0B
Est 354.4B
+1.0%
Nov 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener